← Back to catalogue

Superica Knee Tibial Insert Highly Crosslink Left 14mm Size 1

EUDAMED

Class III (EU MDR)

Ref 65.7014Model SUPERICA KNEE TIBIAL INSERT HIGHLY CROSSLINK LEFT 14MM SIZE 1Ref 65.5014Model SUPERICA KNEE TIBIAL INSERT LEFT 14MM SIZE 1

by Covision Medical Technologies Ltd.

Identity

Trade Name
SUPERICA KNEE TIBIAL INSERT HIGHLY CROSSLINK LEFT 14MM SIZE 1 EUDAMED
SUPERICA KNEE TIBIAL INSERT LEFT 14MM SIZE 1 EUDAMED
Device Name
SUPERICA KNEE TIBIAL INSERT HIGHLY CROSSLINK LEFT 14MM SIZE 1 EUDAMED
SUPERICA KNEE TIBIAL INSERT LEFT 14MM SIZE 1 EUDAMED
Model / Reference
SUPERICA KNEE TIBIAL INSERT HIGHLY CROSSLINK LEFT 14MM SIZE 1 EUDAMED
65.7014 EUDAMED
SUPERICA KNEE TIBIAL INSERT LEFT 14MM SIZE 1 EUDAMED
65.5014 EUDAMED

Identifiers

Primary DI / UDI-DI
05051659173541 EUDAMED
05051659172940 EUDAMED
Basic UDI-DI
B-05051659173541 EUDAMED
B-05051659172940 EUDAMED
EMDN Code
P090903020202 BICOMPARTMENTAL PRIMARY IMPLANT FIXED BEARING TIBIAL INSERTS EUDAMED

Classification

Device Class
Class III EUDAMED
Market of Registration
Austria EUDAMED

Clinical & Handling

Sterile

Yes

EUDAMED

Implantable

Yes

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Superica Knee Tibial Insert Highly Crosslink Left 14mm Size 1 by Covision Medical Technologies Ltd. — Class III — MDD — listed in EUDAMED

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/MDD

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
GB-MF-000025081
Authorised Representative
Covision Medical Technologies (Ireland) Limited IE-AR-000031129

Sources (2)

  • EUDAMED d0805535-b4e5-40e2-90d1-a928416f2e9d 61 fields · synced Jul 10, 2026
  • EUDAMED 4f8c4122-2232-4dc2-b789-52a5d029e707 61 fields · synced May 18, 2026